Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
So many seizures… so many drugs… What to choose and when Courtenay Freeman, DVM, DACVIM (Neurology) Southeast Veterinary Neurology QuickTime™ and a dec ompressor are needed to see this picture. Objectives • Description • Lesion localization • Work up • Management Definitions • Seizure – The clinical manifestation of an abnormal and excessive synchronization of a population of cortical neurons • Epilepsy – Tendency toward recurrent seizures • Unprovoked by systemic or acute neurologic insults Definitions • Prodrome – Longterm indication of seizure – hours to days before seizures • Aura – Initial sensation of seizure before observable signs – seconds-minutes prior to seizure • Ictus – Seizure itself, usually 1-3minutes • Post ictus – Transient abnormalities in brain function – Several hours to 1-2 days, 3-4 days (horses) Classification QuickTime™ and a YUV420 codec decompressor are needed to see this picture. seizure focal No impairment of consciousness Impairment of consciousness generalized Tonic-clonic Absence Myoclonic Secondarily generalizes Tonic/clonic/atonic Classification Seizure Intracranial Structural Functional •Vascular •Infect/infl •Trauma •Anomaly •Neoplasia •Cryptogenic •Inherited/ Idiopathic Extracranial Metabolic Toxic Differentials • Syncope • Narcolepsy/Cataplexy • Vestibular episodes • Movement disorders Narcolepsy QuickTime™ and a Motion JPEG OpenDML decompressor are needed to see this picture. QuickTime™ and a Motion JPEG OpenDML decompressor are needed to see this picture. Idiopathic head bobbing QuickTime™ and a h264 decompressor are needed to see this picture. Lesion Localization • Forebrain or Prosencephalon – Rostral to tentorium cerebelli • Includes • Cerebrum (telencephalon) • Thalamus (diencephalon) Forebrain dysfunction • Altered mental status and behavior changes Gait and Posture • Normal gait – Pleurothotonus • body turn toward lesion – Circling (toward) • Postural reactions – Deficits on contralateral side Menace response • Absent contralateral to lesion • Normal PLR Sensory • Facial hypoalgesia • Hypoaesthesia on contralateral side of body • Hemineglect – Ignore sensory input from one half of their body • Eat out of one half of bowl QuickTime™ and a decompressor are needed to see this picture. Other Seizures!! QuickTime™ and a Motion JPEG OpenDML decompressor are needed to see this picture. Idiopathic epilepsy • Recurrent seizures with no identifiable cause • Genetic predisposition • Cryptogenic epilepsy – No identifiable cause – No genetic predisposition QuickTime™ and a decompressor are needed to see this picture. IE: Signalment • • • • 6 months to 6 years of age Normal neurologic examination Normal inter-ictal examination Purebred dog QuickTime™ and a decompressor are needed to see this picture. QuickTime™ and a decompressor are needed to see this picture. Diagnostics • Minimum data base – CBC – Chemistry Profile – Urinalysis – +/- Liver function tests • Advanced imaging?? Who should be imaged? • Asymmetrical neurologic examination • Abnormal inter-ictal period • Patients > 6 years old • All dogs?? Treatment • Goals? – Maintain seizure control – Limit unacceptable side effects – Seizure control ≠ elimination • When to start? Seizure therapy PRINCIPLES • Life-long daily treatment • Frequent reevaluations are necessary • Potentials for emergency situations • Inherent risks of the drugs Seizure therapy When to start? • • • • Intracranial disease Status epilepticus Cluster seizures 2 or > isolated events in 4 - 6 wk period Phenobarbital – “Broad spectrum” – Increases seizure threshold – Decreases spread of seizures – Good first line drug • Controls ~ 80% of IE dogs Phenobarbital Dose (a) Dog - 2 - 4 mg/kg every 12 hours (b) Cat – 1.5 - 2.5 mg/kg every 12 hours Therapeutic serum concentration (a) Dog - 15 - 40 µg / ml (b) Cats - 23.2 - 30.2 µg / ml How to use PB ? 2-4 mg/kg twice daily 45 15 Dosing interval << T1/2 (accumulation) 5.5 time T1/2 = 10 to 14 days Phenobarbital – T1/2; Steady State (SS) • Dog – 32-90 hours; 10-18 days • Cat – 34-43 hours; 10-14 days • Horse – 14-25 hours; 3-6 days – 90-100% Bioavailable – Peak conc. 4-8hrs – Primarily Hepatic metabolism • Up to 25% excreted unchanged by kidneys Loading Dose Loading 10 to 14 days Total Phenobarbital loading dose: 18 to 24 mg/kg intravenously over 24 hr Phenobarbital: adverse effects Idiosyncratic (1) Hyperexcitability (2) Acute toxic hepatopathy in dogs (3) Immune-mediated bone marrow suppression (4) Lymphadenopathy in cats (pseudolymphoma) (5) Superficial necrotizing dermatitis (6) Facial pruritus and limb edema (cat) QuickTime™ and a decompressor are needed to see this picture. Phenobarbital: adverse effects Dose-related / transient (1) Sedation (2) Polydipsia & polyuria (3) Polyphagia (less common in cats) (4) Pelvic limb weakness Phenobarbital: adverse effects Laboratory changes (1) Elevation of serum ALP (2) Depression of serum albumin (3) Serum T4 and fT4 significantly depressed in 6070% dogs (minimal fluctuation in TT3) (4) Serum TSH may even be elevated in <7% dogs (slow, compensatory) (5) Cholesterol high normal QuickTime™ and a decompressor are needed to see this picture. Potassium Bromide • • • • • No biotransformation Competes with ClHyperpolarization Synergistic effects Controls 80% of refractory cases • Entirely excreted by kidneys Potassium Bromide • • • • 30 mg/kg/day orally T1/2 (dog): 25 to 46 days (cat 10 days) Steady state (dog): 3 to 6 months Serum concentration: 800-1500 µg/mL Potassium Bromide Loading dose : Total dose = 600 mg/kg Divided over 4 days = 150 mg/kg/day Risks = vomiting / extreme sedation Potassium Bromide • PuPd, Polyphagia, • Pruritus • Hyperactivity/ behavioral change • Pancreatitis (with PB)? • Asthma in cats – Allergic Pneumonitis 35-42% – Idiosyncratic – Resolves over 1-2 months Bromism • Dose-dependant • Ataxia, Sedation • Pelvic limb stiffness and weakness Benzodiazepines • Mechanism of Action – Increase the frequency of the chloride channel opening – Hyperpolarizes cell Diazepam • Half-life: – Dogs ~ 3hrs – Cat ~ 8-10hrs • Develop tolerance to medication • Rapid withdrawal may induce seizures Diazepam • Emergency management of seizures • Limited use in dogs • 0.5-1 mg/kg divided bid - tid • Steady state in 3.5 - 4.5 days • Monitor liver enzymes after 5 days due to risk of hepatic necrosis Adjunctive Medication Clorazepate • Metabolized to nordiazepam • Tolerance develops but slower than to diazepam • 0.5 mg/kg q8-12 hrs • Useful for ‘breakthroughs’ as only effective for 2 months Gabapentin / PREGABALIN • Structural analogue of GABA • Binds to the a2-d sub-unit of high voltage pre-synaptic calcium channels – Decreases NT release • Half-life 3-4 hrs • 30% metabolized in liver – rest unchanged in urine Gabapentin (Neurontin) • Metabolized in liver • T1/2 3-4 hrs • 10-20 mg/kg TID PO • 50% improved control • Do not use liquid formulation! Levetiracetam • Binds to a synaptic vesicle (SVA2) – Modulates of neurotransmitter release, reuptake, recycling • Half-Life 2-4 hrs • Excreted primarily through kidney • HONEYMOON EFFECT – Dogs develop recurrence of seizure frequency – tolerance? Levetiracetam • 20 mg/kg tid PO (Keppra XR?) • Use higher dose when with PB • 50% improved control • IV use in emergencies • Ataxia & sedation Zonisamide • Synthetic sulfonamide • “Broad spectrum”/multi-modal • Half-life 17 hrs (dog), ~35 hrs (cat) • Liver metabolism Zonisamide (Zonegran) • 50% refractory epileptics respond • 5-10 mg/kg bid PO • Need increased dose with PB • Side Effects – Transient sedation, ataxia – Acute hepatoxicity (idiosyncratic) – KCS Felbamate • Mechanism of action – Inhibits NMDA and kainate receptor activation – Inhibits voltage dependent Na+ channels • High bioavailability • T ½ of 4-6 hours • 70% excreted in urine unchanged, 30% liver • Side Effects – blood dyscrasias, hepatotoxicity Status epilepticus • Definition: seizure activity > 5 min • Cluster seizures: 2 or > seizures in a 12 to 24 hour period • Anticonvulsants: drug to stop seizure activity • Antiepileptic: drug to prevent seizure activity Status epilepticus ADMISSION MANAGEMENT • History • Rectal temperature – cool if >104˚F/40˚C • Blood work – Electrolytes/ Ca++ / Glucose / bile acids / Toxicity screen / PCV / TP • +/- Dextrose 10% solution; 100 mg/kg IV • Oxygen administration • +/- IV catheter Status epilepticus Treatment #1 • Stop seizure activity 1. Diazepam – 0.5 - 1.0 mg/kg IV, 0.5 - 2.0 mg/kg rectally or IN – Midazolam 0.2 mg/kg IV/IM/nasally 2. Phenobarbital 2-4 mg/kg IV/IM – Onset of action ~20 min – q 30 min intervals if needed (20-24 mg/kg/24 hr) Status epilepticus Treatment #2 • Valium/midazolam CRI – 0.5 - 2.0 mg/kg/hour IV CRI in 0.9% saline – Respiratory depression possible – Reduce dose q3-6 hr to effect Status epilepticus Treatment #3 • Levetiracetam (Keppra) IV • Anticonvulsant and anti-epileptic • 20 to 60 mg/kg IV over 2 minutes lasts 8 hours (dilute) Status epilepticus Treatment #4 • Barbituate coma – Pentobarbital 3 - 24 mg/kg IV to effect – Profound respiratory and cardiac depression – Especially if toxin induced seizures • Propofol coma – – – – Anticonvulsant properties Bolus 1-4 mg/kg IV to effect CRI (0.1-0.6 mg/kg/min) Consider expense Status epilepticus Treatment #5 Last Ditch!! • Inhalational Anesthesia vs. thiopental • Ketamine – 5mg/kg IV then 5 mg/kg/hr • Potassium bromide rectally – 100 mg/kg q4hrs 6 doses Status epilepticus Treatment #6 • Cerebral edema? – Oxygen and Fluids – Methylprednisolone sodium succinate? – Furosemide 1.0 mg/kg IM, IV – Mannitol 20% 0.5 g/kg IV Status epileptus Post seizure management • • • • • • Thoracic and Abdominal imaging Urinalysis / Indwelling urinary catheter ECG CT / MRI CSF +/-Gastric lavage Questions? QuickTime™ and a dec ompressor are needed to see this picture. Courtenay Freeman, DVM, DACVIM (Neurology)